StockData
Fortress Biotech, Inc. logo

Fortress Biotech, Inc. (FBIO) bonds

FBIONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as FBIOP
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/30
$1.82+0.11 (+6.43%)

Close on Nov 17, 2026Market cap $66.94MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Total debt
$34.60M
Long-term debt
Net debt
-$161.97M
After $196.58M of cash
Implied interest rate
18.31%
FY2025 interest ÷ average debt
Interest coverage
-6.9×
FY2025 operating income ÷ interest

Total debt by fiscal year

Long-term plus current debt, USD

When the debt comes due

Principal repayments of long-term debt by fiscal year, as scheduled at Dec 31, 2013

From the debt maturity table in the annual report (filing). “Later” is everything due after year five.

Notes and loans outstanding

As tagged in Fortress Biotech's 10-Q for the period ended Jun 30, 2026

IssueCouponAmount issuedCarrying value
2024 Oaktree Note11.30%$50.00M$15.00M

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

Credit facilities

Revolving credit lines and other committed borrowing capacity

FacilitySizeDrawn
IDB Note Payable––
SWK Term Loan$25.00M$25.00M

See a number that looks wrong?